Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics
Daniel Yoo, Andrew D. Hauser, Stephen T. Joy, et al.
ACS Chemical Biology (2020) Vol. 15, Iss. 6, pp. 1604-1612
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Biospecific Chemistry for Covalent Linking of Biomacromolecules
Li Cao, Lei Wang
Chemical Reviews (2024) Vol. 124, Iss. 13, pp. 8516-8549
Open Access | Times Cited: 11
An mRNA Display Approach for Covalent Targeting of a Staphylococcus aureus Virulence Factor
S P Wang, Emily C. Woods, Jeyun Jo, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Covalent peptides and proteins for therapeutics
Viktoriya Y. Berdan, Paul C. Klauser, Lei Wang
Bioorganic & Medicinal Chemistry (2020) Vol. 29, pp. 115896-115896
Closed Access | Times Cited: 54
Targeting intracellular protein–protein interactions with macrocyclic peptides
Marina Buyanova, Dehua Pei
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 3, pp. 234-248
Open Access | Times Cited: 47
Peptide‐based covalent inhibitors of protein–protein interactions
Felix M. Paulussen, Tom N. Grossmann
Journal of Peptide Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 34
Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex
Felix M. Paulussen, Gina K. Schouten, Carolin Moertl, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 33, pp. 15303-15313
Open Access | Times Cited: 29
Recent progress in targeting KRAS mutant cancers with covalent G12C-specific inhibitors
Lala S. Rathod, Pratap S. Dabhade, Santosh N. Mokale
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103557-103557
Closed Access | Times Cited: 19
Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display
Sabrina E. Iskandar, Lilly Chiou, Thomas Leisner, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 28, pp. 15065-15070
Open Access | Times Cited: 18
Macropinocytosis as a Key Determinant of Peptidomimetic Uptake in Cancer Cells
Daniel Yoo, Stephanie A. Barros, Gordon C. Brown, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 34, pp. 14461-14471
Open Access | Times Cited: 39
Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification
Natsuki Osaka, Yoshihisa Hirota, Doshun Ito, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 26
A Sos proteomimetic as a pan-Ras inhibitor
Seong Ho Hong, Daniel Yoo, Louis P. Conway, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 18
Open Access | Times Cited: 25
Covalent labeling of a chromatin reader domain using proximity-reactive cyclic peptides
Meng Yao Zhang, Hyunjun Yang, Gloria Ortiz, et al.
Chemical Science (2022) Vol. 13, Iss. 22, pp. 6599-6609
Open Access | Times Cited: 19
Design, Synthesis, and Antitumor Activity of Stapled Peptide Inhibitors Targeting the RAS–RAF Interactions
Dan Han, Yu Zhou, Kai Zhang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117568-117568
Closed Access
Site-selective modification of native proteins
Yujun Kim, Han Yi, Kyungdeok Seo, et al.
Trends in Chemistry (2025)
Closed Access
Covalent flexible peptide docking in Rosetta
Barr Tivon, Ronen Gabizon, B. Somsen, et al.
Chemical Science (2021) Vol. 12, Iss. 32, pp. 10836-10847
Open Access | Times Cited: 21
Covalent and Noncovalent Targeting of the Tcf4/β-Catenin Strand Interface with β-Hairpin Mimics
Sarah L. Blosser, Nicholas Sawyer, Igor Maksimovic, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 8, pp. 1518-1525
Open Access | Times Cited: 21
Peptide inhibitors targeting Ras and Ras-associated protein–protein interactions
Dan Han, Anpeng Li, Lie Zhu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116878-116878
Closed Access | Times Cited: 3
SOS1-inspired hydrocarbon-stapled peptide as a pan-Ras inhibitor
Anpeng Li, Xiang Li, Jihua Zou, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106500-106500
Closed Access | Times Cited: 6
Affinity-Driven Aryl Diazonium Labeling of Peptide Receptors on Living Cells
Sheryl Sharma, Michael J. Naldrett, M. GILL, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 19, pp. 13676-13688
Closed Access | Times Cited: 2
Discovering Covalent Cyclic Peptide Inhibitors of Peptidyl Arginine Deiminase 4 (PADI4) Using mRNA-Display with a Genetically Encoded Electrophilic Warhead
Isabel R. Mathiesen, Ewen D. D. Calder, Simone Kunzelmann, et al.
(2024)
Open Access | Times Cited: 2
Discovering covalent cyclic peptide inhibitors of peptidyl arginine deiminase 4 (PADI4) using mRNA-display with a genetically encoded electrophilic warhead
Isabel R. Mathiesen, Ewen D. D. Calder, Simone Kunzelmann, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
An mRNA Display Approach for Covalent Targeting of a Staphylococcus aureus Virulence Factor
S P Wang, Emily C. Woods, Jeyun Jo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Hydrogen bond surrogate helices as minimal mimics of protein α-helices
Ganesh S. Jedhe, Paramjit S. Arora
Methods in enzymology on CD-ROM/Methods in enzymology (2021), pp. 1-25
Closed Access | Times Cited: 9
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Soraya Learte‐Aymamí, Pau Martín-Malpartida, Lorena Roldán-Martín, et al.
Communications Chemistry (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 6
A primer on harnessing non-enzymatic post-translational modifications for drug design
Marcus J. C. Long, Phillippe Ly, Yimon Aye
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 11, pp. 1797-1807
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top